Latest stories on ACET
Adicet Bio reports Q3 EPS ($1.76), consensus ($1.58)
The Fly63 · neutralearnings
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral
Adicet Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates
StockTitan55 · neutralearnings
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Adicet Bio to Participate in Upcoming Investor Conferences
StockTitan52 · neutralgeneral
Adicet Bio, Inc. (ACET) Discusses Positive Prula-cel Data and Plans for Pivotal Study in Lupus Nephritis - Slideshow
Seeking Alpha67 · bullishproduct/pr
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Adicet Bio price target raised to $28 from $25 at Wedbush
The Fly61 · neutralanalyst
Adicet Bio, Inc. (ACET) Discusses Positive Prula-cel Data and Plans for Pivotal Study in Lupus Nephritis Transcript
Seeking Alpha67 · bullishproduct/pr
Wedbush raises Adicet Bio stock price target on lupus trial data
Investing.com Analyst Ratings61 · neutralanalyst
Adicet Bio price target raised to $34 from $27 at H.C. Wainwright
The Fly61 · neutralanalyst
Adicet Bio trading resumes
The Fly50 · neutralgeneral
Adicet Bio trading halted, volatility trading pause
The Fly42 · neutralgeneral
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral
ACET Highlights 54% DORIS Remission at 12 Months in Prula-cel Phase 1 Lupus Study, Setting Up Pivotal LN Plans
September 28, 2026
MarketChameleon73 · bullishproduct/pr
Adicet Bio reports data from Phase 1 study of prula-cel
The Fly59 · neutralproduct/pr
H.C. Wainwright reiterates Adicet Bio stock rating on data update
Investing.com Analyst Ratings56 · neutralanalyst
Adicet data update presents attractive opportunity, says H.C. Wainwright
The Fly63 · neutralproduct/pr
Adicet Bio Highlights Prula-cel Autoimmune CAR-T Pipeline Progress
TipRanks63 · neutralproduct/pr
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral
Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
Adicet Bio completes last patient visit for analysis of prula-cel in lupus
The Fly59 · neutralproduct/pr
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral